Search results
CRYOcheck Abnormal 2 Control, frozen
CRYO check ™ Abnormal 2 Control is recommended for use as abnormal controls for PT and aPTT assays. Contains strongly reduced levels of clotting factors II, VII, IX and X.
CRYOcheck Abnormal 1 Control, frozen
CRYO check ™ Abnormal 1 Control is recommended for use as abnormal controls for PT and aPTT assays. Contains reduced levels of clotting factors II, VII, IX and X.
CRYOcheck™ CorPac™, frozen
CRYOcheck CorPacTM consists of 30 individual vials containing human plasma with distinct prothrombin time (PT), activated partial thromboplastin time (aPTT) and fibrinogen profiles spanning the normal and pathological range.
CRYOcheck Pooled Normal Plasma, frozen
Normal control for prothrombin time (PT) and activated partial thromboplastin time (aPTT) assays. May also be used as an alternative to in-house collected normal plasma pools.
CRYOcheck Pooled Normal Plasma, frozen
Normal control for prothrombin time (PT) and activated partial thromboplastin time (aPTT) assays. May also be used as an alternative to in-house collected normal plasma pools.
CRYOcheck Pooled Normal Plasma, frozen
Normal control for prothrombin time (PT) and activated partial thromboplastin time (aPTT) assays. May also be used as an alternative to in-house collected normal plasma pools.
CRYOcheck Pooled Normal Plasma, frozen
Normal control for prothrombin time (PT) and activated partial thromboplastin time (aPTT) assays. May also be used as an alternative to in-house collected normal plasma pools.
Test system for the determination of Global Fibrinolytic Capacity (GFC)
BIOPHEN Heparin anti-IIa (2-stages kit)
Assay proposed for the measurement of heparin anti-thrombin activity in research applications acc. to Pharmacopoeia.
BIOPHEN Heparin anti-IIa (2-stages) -> SEE NEW REF. 220005
Assay proposed for the measurement of heparin anti-thrombin activity in research applications acc. to Pharmacopoeia.